PSMD4/ASF 抗体
(Proteasome (Prosome, Macropain) 26S Subunit, Non-ATPase, 4 (Psmd4))
The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits\; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the non-ATPase subunits of the 19S regulator lid. Pseudogenes have been identified on chromosomes 10 and 21. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PSMD4/ASF 抗体 (AA 300-328) (APC) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 300-328) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 300-328) (PE) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 347-377) (APC) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 300-328) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 300-328) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 347-377) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 347-377) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 347-377) (PE) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 347-377) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 2-254) | 小鼠 | 山羊 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 300-328) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (Gly344) | 人, 大鼠, 小鼠, 猴 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (Regulatory Subunit) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (Regulatory Subunit) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (Regulatory Subunit) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PSMD4/ASF 抗体 | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| PSMD4/ASF 抗体 (AA 300-328) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 300-328
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 300-328
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 300-328
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 347-377
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 300-328
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 300-328
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 347-377
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 347-377
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 347-377
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 347-377
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 2-254
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 300-328
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠, 小鼠, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Gly344
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 161-377, Regulatory Subunit
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 161-377, Regulatory Subunit
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 161-377, Regulatory Subunit
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 0A11
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 300-328
Latest Publications for our PSMD4/ASF 抗体
: "Glatiramer acetate and nanny proteins restrict access of the multiple sclerosis autoantigen myelin basic protein to the 26S proteasome." in: BioMed research international, Vol. 2014, pp. 926394, (2014) (PubMed).
: "Functional differences between two major ubiquitin receptors in the proteasome; S5a and hRpn13." in: Biochemical and biophysical research communications, Vol. 396, Issue 2, pp. 425-8, (2010) (PubMed).
: "Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15." in: The Journal of biological chemistry, Vol. 285, Issue 2, pp. 1424-34, (2010) (PubMed).
: "Structure of the s5a:k48-linked diubiquitin complex and its interactions with rpn13." in: Molecular cell, Vol. 35, Issue 3, pp. 280-90, (2009) (PubMed).
: "S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains." in: The EMBO journal, Vol. 28, Issue 13, pp. 1867-77, (2009) (PubMed).
: "The immunomodulatory role of angiocidin, a novel angiogenesis inhibitor." in: Current pharmaceutical design, Vol. 15, Issue 17, pp. 1937-48, (2009) (PubMed).
: "Age-related modifications of egr1 expression and ubiquitin-proteasome components in pet dog hippocampus." in: Mechanisms of ageing and development, Vol. 130, Issue 5, pp. 320-7, (2009) (PubMed).
: "Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a." in: Biochemistry, Vol. 41, Issue 6, pp. 1767-77, (2002) (PubMed).
: "Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis." in: The Journal of biological chemistry, Vol. 275, Issue 19, pp. 14336-45, (2000) (PubMed).
: "Developmentally regulated, alternative splicing of the Rpn10 gene generates multiple forms of 26S proteasomes." in: The EMBO journal, Vol. 19, Issue 15, pp. 4144-53, (2000) (PubMed).
: "Functional differences between two major ubiquitin receptors in the proteasome; S5a and hRpn13." in: Biochemical and biophysical research communications, Vol. 396, Issue 2, pp. 425-8, (2010) (PubMed).
: "Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15." in: The Journal of biological chemistry, Vol. 285, Issue 2, pp. 1424-34, (2010) (PubMed).
: "Structure of the s5a:k48-linked diubiquitin complex and its interactions with rpn13." in: Molecular cell, Vol. 35, Issue 3, pp. 280-90, (2009) (PubMed).
: "S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains." in: The EMBO journal, Vol. 28, Issue 13, pp. 1867-77, (2009) (PubMed).
: "The immunomodulatory role of angiocidin, a novel angiogenesis inhibitor." in: Current pharmaceutical design, Vol. 15, Issue 17, pp. 1937-48, (2009) (PubMed).
: "Age-related modifications of egr1 expression and ubiquitin-proteasome components in pet dog hippocampus." in: Mechanisms of ageing and development, Vol. 130, Issue 5, pp. 320-7, (2009) (PubMed).
: "Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a." in: Biochemistry, Vol. 41, Issue 6, pp. 1767-77, (2002) (PubMed).
: "Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis." in: The Journal of biological chemistry, Vol. 275, Issue 19, pp. 14336-45, (2000) (PubMed).
: "Developmentally regulated, alternative splicing of the Rpn10 gene generates multiple forms of 26S proteasomes." in: The EMBO journal, Vol. 19, Issue 15, pp. 4144-53, (2000) (PubMed).
Aliases for PSMD4/ASF 抗体
proteasome 26S subunit, non-ATPase 4 (psmd4) 抗体proteasome 26S subunit, non-ATPase 4 (PSMD4) 抗体
26S proteasome non-ATPase regulatory subunit 4 (LOC100194679) 抗体
26S proteasome non-ATPase regulatory subunit 4 (psmD4) 抗体
26S proteasome non-ATPase regulatory subunit 4 (LOC100283637) 抗体
26s proteasome non-atpase regulatory subunit 4 (26s proteasomeregulatory subunit s5a) (Smp_000740.1) 抗体
proteasome 26S subunit, non-ATPase 4 L homeolog (psmd4.L) 抗体
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 (Psmd4) 抗体
proteasome 26S subunit, non-ATPase 4 (Psmd4) 抗体
proteasome 26S subunit, non-ATPase 4b (psmd4b) 抗体
AF 抗体
af-1 抗体
AF-1 抗体
Af1 抗体
angiocidin 抗体
ASF 抗体
DDBDRAFT_0202512 抗体
DDBDRAFT_0232981 抗体
DDB_0202512 抗体
DDB_0232981 抗体
im:6912672 抗体
mcb1 抗体
MCB1 抗体
Mcb1 抗体
PSMD4 抗体
psmd4 抗体
pub-r5 抗体
pUB-R5 抗体
rpn10 抗体
Rpn10 抗体
S5A 抗体
wu:fc68c04 抗体
xrpn10c 抗体
zgc:110247 抗体
您还需要查找其他产品吗？
You are here:
